Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate plus remifentanil versus propofol plus remifentanil in elderly cataract surgery
ChiCTR2200063250Phase 4Not yet recruiting
- Sponsor
- Beijing Huaxin Hospital
- Start
- Sep 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam, remifentanil and propofol in cataract (2 arms), sponsored by Beijing Huaxin Hospital. Primary endpoints: Wake-up time and Duration of anesthesia induction. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
remimazolamremifentanilpropofol
03
Conditions
cataract
Beyond the preview
Go deeper on ChiCTR2200063250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063250.